4 EVENTS IN ONE:Day 1-2: 3rd Annual - International Pharmaceutical Payers’ & HTA Summit: Managing a Limited Budget for Expensive Medicines Whilst Encouraging InnovationDay 3: STREAM 1 - 3rd Annual – AMNOG in Action: Experiences with the German Pharmaceutical Pricing & Reimbursement ReformDay 3: STREAM 2 - 2nd Annual - Market Access for High Value Specialty & Biologic MedicinesDay 3: STREAM 3 - Market Access for Vaccines & Infectious Disease Medications This is the must-attend event for all senior Market Access, HEOR, and Government Affairs directors from leading pharma and biotechnology companies. This 3 day event will give all attendees the insight and understanding of HTA, payer & market access stakeholders' decision-making processes and evaluation methods. It is designed so that the experiences over the 3 days are as value-adding and specifically relevant for every participant. Attendees will be able to understand and develop best practice approaches to vital and common patient access challenges, with the ultimate goal of encouraging innovation and improving access to novel and powerful medications which demonstrate “real value” to payers in their terms.